UpdatesPress Release
Aakaar Medical Technologies reported strong H2 & FY26 financial results.
Aakaar Medical Technologies LimitedAAKAAR · Filed with the exchange
H2 revenue reached 41.6 Cr and PAT 7.4 Cr, rebounding from H1 losses.
The company launched four new high-growth brands and unveiled XELIX, a doctor-owned aesthetics platform leveraging its 6300+ doctor network.
No comments yet. Be the first.